Flibanserin, the female libido enhancing drug, has been shrouded in controversy but if the FDA approves it, it could translate into a $2 billion market in the U.S. alone. Dr. Jennifer Ashton reports.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
